Compare Baxter International Inc (BAX) vs Mondaycom Ltd (MNDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Mondaycom Ltd — how do they compare? Baxter International Inc trades at $21.78 (market cap $11.26B), while Mondaycom Ltd trades at $82.6 (market cap $3.51B). The key difference: Baxter International Inc is far larger — about 3.2× Mondaycom Ltd's market cap, and Baxter International Inc pays a 0.92% dividend while Mondaycom Ltd pays none. Which is the better fit depends on your goals.
| BAX | MNDY | |
|---|---|---|
Market Cap | $11.26B | $3.51B |
Sector | Health | Technology |
52-Week High | $29.22 | $292.24 |
52-Week Low | $15.80 | $58.81 |
Enterprise Value | $18.93B | $2.47B |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Baxter International (BAX) trades at $22.57, down 0.22% on the day, with mixed technical signals showing a bullish moving average trend but neutral oscillators. The company reported Q1 2026 earnings beat with $0.36 EPS versus $0.31 expected, though net income margin remains negative at -9.7%. Recent news highlights upcoming Q2 earnings call and sustainability initiatives, while analyst consensus sits at $22.67 price target with 42% buy ratings.
BAX faces fundamental challenges with negative profitability metrics and volatile cash flow, but valuation appears reasonable with P/S of 1.02. The stock offers potential upside to analyst targets if operational improvements materialize, though investors must weigh high debt levels and inconsistent earnings performance against turnaround prospects in the medical technology sector.
Monday.com (MNDY) trades at $86.84, up 5.3% in the past 24 hours, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings expectations, with Q1 2026 EPS of $1.15 surpassing the $0.96 estimate. Revenue grew to $1.23 billion in 2025, though net income remained flat at $119 million year-over-year. Recent news highlights investor attention amid a 51% decline in the first half of 2026, with some viewing the dip as a buying opportunity due to solid fundamentals.
The outlook for MNDY is positive, driven by robust revenue growth, high gross margins of 89.05%, and a unanimous analyst buy consensus with a $115.50 price target. Key risks include elevated valuation multiples, competitive pressures in the SaaS space, and volatility from AI disruption concerns. Investors should weigh the company's execution against its premium pricing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Mondaycom Ltd
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →
